Towards implementation of precision medicine biomarkers in early detection and prognostication of prostate cancer

Cancer and Metastasis Reviews · Published 2026-07-23 · DOI 10.1007/s10555-026-10357-8

Free full text

Authors (6)

Angela Yee, Jim Smith, Rajiv Kumar, Akash Sali, Euan J. Rodger, Aniruddha Chatterjee

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yee, A., Smith, J., Kumar, R., et al. (2026). Towards implementation of precision medicine biomarkers in early detection and prognostication of prostate cancer. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-026-10357-8

Related articles

• Single-cell and spatial RNA sequencing in prostate cancer · Nature Reviews Urology · 2026 · Cites or is cited by this article
• Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies · Research and Reports in Urology · 2025 · Cites or is cited by this article
• Written in blood: DNA methylation in liquid biopsy · Nature Reviews Genetics · 2026 · Cites or is cited by this article
• Plasma circulating tumor DNA methylation enables non-invasive disease stratification beyond PSA in prostate cancer · Prostate International · 2025 · Cites or is cited by this article
• From bench to bedside: advancing our understanding of radioresistance in rectal cancer · Cancer and Metastasis Reviews · 2026 · Same journal
• Ferroptosis at the intersection of radiotherapy and immunotherapy · Cancer and Metastasis Reviews · 2025 · Same journal
• The link between microplastics and colorectal cancer · Cancer and Metastasis Reviews · 2026 · Same journal
• Tumor exosomes impact functional hallmarks of cancer · Cancer and Metastasis Reviews · 2026 · Same journal
• Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group · Cancer and Metastasis Reviews · 2025 · Same journal
• Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development · Cancer and Metastasis Reviews · 2026 · Same journal